-+ 0.00%
-+ 0.00%
-+ 0.00%

Innate Pharma Proposes Transition To CEO And Board Of Directors Governance Model At May 22 Annual General Meeting

Benzinga·04/16/2025 05:40:36
Listen to the news
  • Innate to propose to its Annual General Meeting taking place on May 22, 2025, to move from an executive board/supervisory board corporate governance structure to a CEO/board of directors
  • Irina Staatz-Granzer, current Chairwoman of the Supervisory board would be appointed Chairwoman of the board of Directors
  • Jonathan Dickinson, current Chairman of the Executive board would be appointed Chief Executive Officer and named to the board of Directors
  • Two new members would join the board of Directors